ADRB2 and amyloidosis: Chronic stimulation of β2-ARs in preclinical models, such as the 5xFAD mouse model of AD, has resulted in lower amyloid plaque burdens and improved neuritic integrity, suggesting that microglial β2-AR signaling not only limits amyloid deposition but also preserves neurons [10].